1. Meaning 

The Cognitive Biomarker Doctrine of Accountability is a proposed legal and governance framework for determining responsibility when cognitive biomarkers are collected, interpreted, stored, or used to make decisions affecting individuals.

It concerns the accountability of researchers, healthcare professionals, technology companies, employers, insurers, educational institutions, and government authorities that use biological or neurological indicators to infer a person's cognitive condition or functioning.

Important legal clarification: As of November 2026, this is best understood as an emerging legal concept, not a universally recognized, standalone doctrine established by a particular statute or judicial precedent. Its principles can be developed from existing law concerning privacy, informed consent, medical negligence, discrimination, scientific reliability, data protection, and constitutional rights.

What is a cognitive biomarker?

A cognitive biomarker is a measurable biological or physiological characteristic that may provide evidence about cognitive processes or neurological conditions.

Examples include:

Neural signals: EEG patterns associated with attention, sleep, or particular cognitive tasks.

Neuroimaging indicators: Brain imaging measurements studied for their relationship with memory, neurological disorders, or cognitive function.

Physiological indicators: Eye movements, pupil responses, or other physiological measurements used to estimate attention or mental workload.

Molecular biomarkers: Biological measurements investigated for their relationship with neurological disease or cognitive decline.

A biomarker generally provides evidence or a probabilistic indication. It does not automatically establish a person's intentions, intelligence, honesty, competence, or mental state.

For example, an employer might use an EEG-based system to estimate whether a worker is fatigued. If the system incorrectly classifies the worker as cognitively impaired and the employer dismisses them without verification, several legal questions arise: Was the technology sufficiently validated? Was the data collected lawfully? Was the decision discriminatory? Who must answer for the resulting harm?

The doctrine addresses these questions by connecting scientific reliability with legal responsibility.

2. Core principles of accountability

1. Scientific reliability

A cognitive biomarker must be validated for the specific purpose for which it is used. Evidence that a marker correlates with a condition does not necessarily establish that it can reliably diagnose that condition or predict an individual's behaviour.

2. Informed consent and autonomy

Individuals should understand what is measured, what conclusions may be drawn, who receives the results, and the consequences of participation, subject to applicable legal exceptions.

3. Cognitive privacy

Neural and cognitive information can reveal sensitive aspects of a person's life. Collection and use should be limited to lawful, justified purposes with appropriate security and access controls.

4. Non-discrimination

A biomarker result should not become an unjustified basis for denying employment, education, insurance, healthcare, or public benefits.

5. Traceability and answerability

Organisations should preserve records of data collection, model versions, validation, interpretation, access, and decisions so that errors and misconduct can be investigated.

These principles are a proposed synthesis of established legal duties, rather than five elements expressly enacted together in one law.

3. Major case laws and their legal significance

The following judgments establish legal principles that can be applied to disputes involving cognitive biomarkers. They did not directly establish a doctrine bearing this exact name; their relevance is analogical and depends on the facts and applicable jurisdiction.

Case 1: Justice K.S. Puttaswamy (Retd.) v. Union of India (2017)

Supreme Court of India · (2017) 10 SCC 1

Legal issue: Whether privacy is a constitutionally protected fundamental right.

Judgment: The nine-judge Constitution Bench recognized privacy as an intrinsic part of the fundamental rights protected by the Constitution, including Article 21, and connected it with dignity and personal liberty.

Indian Kanoon+1

Application to cognitive biomarkers:

Brain-related measurements and cognitive profiles may implicate informational privacy.

State collection or use of such information must be assessed under applicable constitutional standards.

Intrusive monitoring may raise questions of necessity, proportionality, and adequate legal safeguards.

Individuals should not be subjected to unjustified surveillance merely because technology can infer aspects of their mental functioning.

Accountability principle: An organisation or public authority should be able to justify why cognitive information is collected, how it is used, and what safeguards prevent misuse.

Limitation: Puttaswamy did not specifically decide the legality of EEG-based cognitive profiling or establish a freestanding constitutional right to neurally private thought.

Case 2: K.S. Puttaswamy v. Union of India (Aadhaar judgment, 2018)

Supreme Court of India · (2019) 1 SCC 1

Legal issue: Whether the Aadhaar identification framework and its collection and use of personal and biometric information complied with constitutional requirements.

Judgment: The Court upheld aspects of the Aadhaar framework while invalidating or restricting other provisions. The opinions addressed privacy, statutory safeguards, purpose limitations, and proportionality.

National Digital Library of India+1

Application to cognitive biomarkers:

The judgment provides a useful analogy for assessing systems that collect neurological or physiological measurements for identification, verification, or administrative decision-making.

A legal assessment should consider:

Whether the collection has a valid legal basis.

Whether the stated objective is legitimate.

Whether the data collected is necessary for that objective.

Whether less intrusive alternatives are available.

Whether safeguards adequately limit disclosure, retention, and secondary use.

Accountability principle: Technical capability alone does not justify collecting or using sensitive biological information. The legal purpose and proportionality of the measure matter.

Limitation: Aadhaar biometrics are primarily identity-related; they are not equivalent to biomarkers used to infer attention, memory, fatigue, or other cognitive characteristics.

Case 3: Daubert v. Merrell Dow Pharmaceuticals, Inc. (1993)

United States Supreme Court · 509 U.S. 579 (1993)

Legal issue: When may scientific expert evidence be admitted in federal court?

Judgment: The Court assigned judges a gatekeeping role in assessing whether expert evidence is scientifically reliable and relevant. Relevant considerations include testability, peer review, potential error rates, standards, and acceptance within the scientific community.

Justia U.S. Supreme Court Center+1

Application to cognitive biomarkers:

Suppose a company claims that a brainwave pattern reliably proves that an employee is inattentive or unfit for work. In litigation, a court may need to examine:

Whether the technique has been empirically tested.

Whether its error rate is known.

Whether the study population resembles the person being assessed.

Whether the method supports the particular conclusion being asserted.

Whether the expert has accounted for alternative explanations.

Accountability principle: A party relying on a cognitive biomarker should not treat a scientific-sounding result as conclusive proof without demonstrating its relevance and reliability.

Limitation: Daubert governs the admissibility of expert evidence under US federal law. It is not a universal rule governing every workplace, clinical, or administrative use of biomarkers, and Indian courts apply their own evidentiary framework.

Case 4: Frye v. United States (1923)

United States Court of Appeals for the District of Columbia · 293 F. 1013

Legal issue: Whether evidence derived from a then-novel deception-detection technique could be admitted.

Judgment: The court applied a general-acceptance standard requiring the underlying scientific principle or technique to have gained sufficient recognition in the relevant scientific field.

Application to cognitive biomarkers:

The case illustrates the danger of relying on a novel cognitive test before the scientific community has established its reliability. A new algorithm that claims to detect dishonesty from brain activity should not be presumed accurate merely because it is technologically sophisticated.

Accountability principle: Novel methods require scrutiny, transparent evidence, and appropriately qualified expert interpretation.

Limitation: In US federal courts, Daubert displaced Frye as the controlling general standard under the Federal Rules of Evidence. Some jurisdictions continue to use general-acceptance tests or related approaches.

Case 5: Montgomery v. Lanarkshire Health Board (2015)

UK Supreme Court · [2015] UKSC 11

Legal issue: The standard for disclosing material risks and reasonable alternatives in medical treatment.

Judgment: The UK Supreme Court held that doctors must take reasonable care to ensure that patients are aware of material risks and of reasonable alternative or variant treatments. The assessment of materiality includes what a reasonable person in the patient's position would consider significant and what the doctor should reasonably know matters to that particular patient.

Application to cognitive biomarkers:

If a clinician recommends a cognitive biomarker test, the clinician should explain its intended purpose, significant limitations, relevant risks, and reasonable alternatives where required by applicable law.

For example, a patient should not be led to believe that an experimental cognitive prediction is a definitive diagnosis when its accuracy and limitations are uncertain.

Accountability principle: Meaningful patient decision-making requires appropriate disclosure, not merely obtaining a signature on a consent form.

Limitation: This is an English medical-consent judgment. Its principles are persuasive by analogy in other jurisdictions, but it does not directly regulate every non-medical cognitive-monitoring system.

Case 6: Bolam v. Friern Hospital Management Committee (1957)

High Court of Justice, England · [1957] 1 WLR 582

Legal issue: The standard of care expected of medical professionals.

Judgment: The traditional Bolam test asks whether a professional acted in accordance with a practice accepted as proper by a responsible body of professional opinion. Its application and scope have been qualified by later decisions, particularly concerning disclosure of risks.

Application to cognitive biomarkers:

A healthcare professional using a cognitive biomarker should act consistently with applicable professional standards, scientific evidence, and the standard of care required by the jurisdiction.

Negligence may arise if a professional relies carelessly on an inadequately validated test, fails to interpret it competently, or overlooks clinically significant contradictory evidence.

Accountability principle: Responsibility is not necessarily avoided merely because a clinician used a commercially available device or followed a software recommendation.

Limitation: Bolam is not a special rule for cognitive biomarkers. Medical negligence must be assessed under the applicable legal standard, and the test does not automatically determine liability in every jurisdiction.

4. Indian statutory and constitutional framework

For disputes in India, the proposed doctrine would operate through existing legal provisions rather than as an independent cause of action.

The Digital Personal Data Protection Act, 2023

The Act provides a statutory framework for digital personal data processing, including lawful-purpose requirements, consent, notice, and obligations of data fiduciaries. Whether a particular cognitive biomarker falls within its scope depends on the nature of the information, the processing involved, and applicable statutory provisions and exemptions.

World Legislative Information Center+1

The Act does not create a separate category of legally protected “cognitive biomarkers” by that name. Nor should it be assumed that every neural measurement automatically qualifies as a specially classified category of sensitive personal data under Indian law.

An accountability assessment should examine:

Lawful basis: Was the data processed under a legally permitted basis?

Purpose limitation: Was the information used for the purpose communicated or otherwise permitted by law?

Data minimisation: Was the information collected necessary for the specified purpose?

Security: Were appropriate safeguards used to prevent unauthorised access or disclosure?

Individual rights and grievance procedures: Were applicable rights and remedies respected?

Regulatory compliance: Were the provisions and rules applicable at the relevant time followed?

The Act contains a phased commencement mechanism, so the legal position must be checked against the commencement notifications and rules applicable on the date of the disputed conduct.

World Legislative Information Center+1

5. Who is legally accountable?

Accountability should follow the conduct, control, legal duties, and contribution to the harm of each participant. Multiple parties may be responsible for different failures in the same incident.

Researchers and laboratories

Responsible for research integrity, appropriate validation, ethical approvals where required, and accurate reporting of limitations.

Device manufacturers and software developers

May be liable under applicable law for defective products, misleading claims, negligent design, or failures to meet relevant regulatory duties.

Clinicians and healthcare institutions

Must meet applicable professional standards when interpreting results and making consequential clinical decisions.

Employers, insurers, and educational institutions

Must comply with applicable privacy, equality, employment, consumer, and sector-specific requirements when using cognitive assessments.

Public authorities

Must act within their statutory powers and comply with constitutional constraints when deploying cognitive surveillance or assessment systems.

Importantly, responsibility is not automatic. A claimant generally must establish the elements of the relevant legal claim, such as breach of duty, unlawful processing, discrimination, causation, and legally cognisable harm, as applicable.

6. Types of legal liability

A. Civil liability

Civil liability may arise where a negligent or unlawful use of a cognitive biomarker causes a legally recognised injury. Depending on the jurisdiction, remedies may include compensation, injunctions, or corrective action.

Example: A healthcare provider negligently interprets an unreliable biomarker, leading to inappropriate treatment and demonstrable injury.

B. Data-protection liability

Unauthorised disclosure, unlawful secondary use, or failure to comply with applicable security requirements may trigger statutory remedies or penalties.

Example: A company shares employees' cognitive profiles with an unrelated commercial entity without an adequate legal basis.

C. Discrimination liability

An institution may face legal consequences if it uses a cognitive score to exclude people unlawfully or relies on a method that produces discriminatory outcomes in circumstances covered by applicable law.

Example: An employer automatically rejects applicants because an algorithm labels them as having low attention capacity, without establishing that the measure is job-related or legally appropriate.

D. Professional or regulatory liability

Medical professionals, laboratories, and regulated device providers may face disciplinary or regulatory proceedings for violations of applicable professional or safety requirements.

E. Criminal liability

Criminal responsibility is possible only where the facts satisfy the elements of a specific offence, such as an applicable offence involving fraud, unlawful access, or other prohibited conduct. An inaccurate biomarker result alone does not automatically constitute a crime.

7. Proposed framework for implementing the doctrine

The following is a practical governance model derived from the legal principles discussed above.

Before collection: Establish a lawful basis, define the intended purpose, assess necessity, and obtain any required informed consent.

Before deployment: Validate the biomarker for the intended population and use; document error rates, limitations, and foreseeable risks.

During use: Restrict access, secure the data, monitor performance, and prevent unauthorised secondary use.

Before consequential decisions: Require proportionate human review where appropriate, verify uncertain results, and provide a meaningful opportunity to challenge an adverse decision.

After an incident: Preserve audit records, investigate the failure, notify affected people or authorities where required, and provide available remedies.

A particularly important distinction is between measurement, inference, and decision. A recorded neural signal is a measurement; a model's estimate of fatigue is an inference; dismissal from employment is a decision. Each stage has different sources of error and may involve different responsible parties.

8. Applying the doctrine to a hypothetical case

Assume a company introduces a brainwave-based system to screen job applicants. The system labels one applicant as cognitively unreliable, and the company rejects the application without further assessment.

A court or regulator could examine the following issues:

Daubert provides an analogy for assessing the reliability of scientific evidence in US federal litigation, while Puttaswamy supplies relevant constitutional privacy principles in India. Neither judgment, by itself, determines the outcome of this hypothetical employment dispute.

The outcome would depend on the applicable employment and data-protection laws, the scientific evidence, the company's conduct, and the harm established.

9. Critical legal challenges

The doctrine faces several unresolved questions:

Scientific uncertainty: How much evidence should be required before a biomarker can support a high-stakes decision?

False positives: Who bears responsibility when an apparently abnormal result incorrectly classifies a healthy individual?

Automated decision-making: How should responsibility be divided between developers, deployers, and human decision-makers?

Consent under pressure: Is participation genuinely voluntary when refusing an assessment means losing employment or access to a service?

Cognitive autonomy: How should the law address systems that infer mental states without directly measuring thoughts or intentions?

Remedies: What evidence must an affected person obtain to prove that an inaccurate inference caused a particular injury?

These questions support the case for clearer sector-specific legislation, independent validation standards, audit obligations, and effective avenues of redress.

10. Conclusion

The Cognitive Biomarker Doctrine of Accountability can be understood as a proposed framework for ensuring that the collection and use of cognitive and neurological measurements remain scientifically defensible, legally justified, transparent, and subject to effective review.

Its strongest existing legal foundations are:

Constitutional privacy and proportionality principles under Puttaswamy in India.

Scientific reliability and relevance principles under Daubert in US federal courts.

Informed-consent principles under Montgomery in English medical law.

Professional standards of care under the applicable medical negligence framework.

Statutory data-protection, equality, consumer, and sector-specific obligations.

The central proposition is that the availability of a cognitive biomarker does not itself justify a consequential decision based on that biomarker. The scientific inference, the legality of processing, the decision-making procedure, and any resulting harm must each be examined under the law applicable to the circumstances.

For a more advanced legal analysis, the next useful step would be to develop this into a jurisdiction-specific research paper covering Indian constitutional law, statutory provisions, comparative case law, and a proposed accountability test for courts and regulators.